Events
Seminars In Venture Capital and Nanotechnology Commercialisation
| Date: | Friday 31 March 2006 14:00 - 18:00 |
| Location: | Laws 2.10 |
Seminar 10: The Venture Capital Process: the views of a senior practitioner from 3i.
Question and Answer Session with Dr Patrick Sheehan, Partner,3i, Chair of Software Activities of 3i, and is also involved in semiconductors and other advanced technologies areas.
www.3i.com/contacts/biographies/patricksheehan.html
2:00-2:45 pm
Seminar 11 : 'Golden Geese in the time of Bird Flu - The Commercialisation of Nanotechnology
3:00-4:15pm
Dr Steffi Friedrichs ,Dipl. Chem. (TU Braunschweig, 1999), DPhil (Oxford, 2002), Dipl. L.a.T.H.E. (Oxford, 2003)
Dr Steffi Friedrichs is a nanotechnology consultant at The Technology Partnership plc., in Melbourn near Cambridge, where, amongst many other things, she is responsible for the development of nanotechnological innovations and contributes to the tendering and due diligence processes for the MNT Network (Department of Trade and Industry, UK Government). Steffi is a co-founder of the International Committee of the NanoBusiness Alliance and a member of the advisory board of the Institute of Nanotechnology.
Steffi started her scientific career by completing her undergraduate degree in 'Diplom-Chemie' at the Technical University of Braunschweig (Germany), before coming to the UK to take a DPhil at the University of Oxford, specialising in the synthesis and characterisation of single-walled carbon nanotubes (SWNTs) and their advanced inorganic encapsulation composites. She subsequently held a Fellowship at Oxford University and a Lectureship in Nanotechnology at Cambridge University, where she developed and co-ordinated a Master’s Programme in Micro- & Nanotechnology Enterprise (funded by the Cambridge-MIT-Institute). Her research efforts expanded into the investigation of the biomimetic assembly (and templating) of (inorganic) nanostructures and the development of ultra-light, long-lasting heterogeneous catalysts based on novel nanostructured supports. She furthermore recently started a project concerned with determining the interaction between nanoparticles and living tissue via electron microscopy; this interdisciplinary project is conducted in collaboration with a number of Departments at the University of Cambridge.
Additional to her scientific qualifications, Steffi completed a diploma in learning and teaching in higher education and is engaged in the promotion of women in science, technology and engineering. She has recently been appointed Chair of the UK Committee for the Recognition of Nanoscience and –technology Educational Programmes (Institute of Nanotechnology).
Seminar 12 : Commercialising Nanomaterials : the Experience of QinetiQ Nanomaterials
Dr Paul Reip, Chief Technology Officer, QinetiQ Nanomaterials
4:30-6:00pm
Dr Paul Reip has a PhD in Materials from Brunel University, and joined the UK MOD in 1982. He spent the early part of his career as research scientist in the EM Gun programme, and then moved on to the RF research programmes as Project Manager, where he was heavily involved in International Collaboration, predominantly with the USA but also Europe and NATO. He was promoted to Department Manager Electro Optic Warfare in 1995, and in 1998 moved back to lead the Guns and Warheads Department. During this time he founded and laid the groundwork for the Corporate Venture that has become QinetiQ Nanomaterials Ltd, a wholly owned subsidiary of QinetiQ, and is now Chief Technology Officer.
